Hologic Expands Healthcare Investment in Asia
Opens State-of-the Art Training Center, Regional Headquarters, and Service Center in Hong Kong

BEDFORD, Mass., Oct. 19, 2009  /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the opening of its new Asia Pacific regional offices and the Hologic Asia Pacific Center for Health Sciences Education in Hong Kong. Sales, product support, training, R&D, logistics, health sciences education, and service for Hologic's breast health, diagnostics, GYN surgical, and skeletal health businesses for the Asia Pacific market will be coordinated from the new facility. Company officials joined country and local leaders, customers and medical luminaries for an opening ceremony at the new facility dedication in the Hong Kong Science Park.

Commenting on the new facility, Jack Cumming, Hologic chairman and chief executive officer said, "This new regional headquarters is another step in our drive to leverage complementary, best-in-class products and technologies to better meet local market needs while driving enhanced growth and value creation for Hologic, our dealers and their customers. With this new facility, we can now offer, in one location, training and educational programs for doctors, radiologists, cytologists, technologists, and application and service support personnel for all our product lines. The investment in Asia is another positive step in Hologic's strategic initiative to expand its international footprint with future plans for regional centers in India and South America."

Paul Young, managing director of Hologic's Asia Pacific region noted, "The Hong Kong facility is complementary to similar Hologic facilities in Boston, Massachusetts, Brussels, Belgium, and London, U.K., and another important step in the process of building regional centers to better serve local needs in all regions of the world."

"The dedication of the sales, service and support associates of Hologic is a key reason for the Company's success," Mr. Cumming noted. "The associates working from the new Hong Kong headquarters are part of a network of more than 4,000 Hologic team members who have come together to redefine what is possible. They work on healthcare initiatives that save lives. Their shared goal is to have each Hologic product be best in class, offering more health, more life, and more hope for more women."

The address of the new facility is:

Hologic Asia Pacific Limited
7th Floor, Biotech Centre 2
No. 11 Science Park West Avenue
Hong Kong Science Park
Shatin, New Territories, HONG KONG

About Hologic
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including HPV and reagents for a variety of DNA and RNA analysis applications.

Forward Looking Statement Disclaimer
This News Release contains forward looking information that involves risks and uncertainties, including statements about Hologic's plans, objectives, expectations and intentions. Such statements include, without limitation, statements regarding the expected benefits of its new Asia Pacific headquarters facility. These forward looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to the data or statements presented herein to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such data or statements are based. Certain factors that could adversely affect the Company's business and prospects are described in Hologic filings with the Securities and Exchange Commission.

 

Contact:

Jim Culley
Corporate Marketing
Hologic, Inc.
Boston, Mass. USA
Tel: +1(302) 528-1312
jim.culley@hologic.com


Sk Tse (Siu-Kai Tse)
HK Managing Director, Far East Sales
Hologic Asia Pacific Limited
Hong Kong, China
Tel: +(852) 3748 7700
siu-kai.tse@hologic.com